XOM vs ABT Stock Comparison: Price, Growth & Valuation (2026)
Use MEXC Stock Compare for a detailed XOM vs ABT analysis. Compare XOM and ABT across price performance, growth, valuation, profitability and risk, based on market data and the latest reported financials.
XOM vs ABT Stock Comparison Summary
XOM reported year-over-year revenue growth of 9.1%, compared with -- for ABT. Their P/E ratios are -- and --, dividend yields are -- and --, and 30-day volatility levels are 24.5% and 19.7%, respectively. These metrics highlight key differences in growth, valuation, dividend income and market risk. Overall ABT leads across more of the selected comparison metrics.
Risk Disclaimer: MEXC Stock Compare provides information and comparisons on actual U.S.-listed stocks for reference only. Data may be delayed or inaccurate, does not constitute investment advice, and past performance does not guarantee future results.
XOM vs ABT Stock Return Comparison (1W)
Compare the cumulative total returns of ExxonMobil Holdings Corporation (XOM) and Abbott Laboratories (ABT) over the selected 1W period. Data as of 2026-09-24 12:00:00.
XOM vs ABT Key Equity Metrics Comparison Summary
ExxonMobil Holdings Corporation (XOM) has a market capitalization of $652.60B and operates in the Energy sector, with its main business classified under Integrated Oil & Gas. Its latest quarterly revenue changed +9.1% year over year.
Abbott Laboratories (ABT) has a market capitalization of $179.04B and operates in the Health Care sector, with its main business classified under Health Care Equipment. Its latest quarterly revenue changed -- year over year.
XOM vs ABT Key Stock Indicators
| Comparison Metric | XOM | ABT | Comparison results |
Stock Price & Returns Latest delayed stock price with 1-day, 1-month and year-to-date returns. | $162.541D: +2.1%1M: +4.0%1Y: +41.9% | $103.471D: -0.5%1M: -10.1%1Y: -22.7% | XOMWin |
Market Capitalization Total market value of the company's outstanding shares. | $652.60B | $179.04B | XOMWin |
Sector & Industry The company's market sector and primary industry classification. | Energy / Integrated Oil & Gas | Health Care / Health Care Equipment | -- |
| Based on delayed market data, XOM is trading at $162.54, compared with $103.47 for ABT. Their market capitalizations are $652.60B and $179.04B, respectively. XOM operates in the Energy sector, while ABT belongs to Health Care. | |||
| XOM vs ABT Growth & Profitability | |||
Revenue Growth (YoY) Year-over-year change in revenue. | +9.1% | -- | -- |
EPS Growth (YoY) Year-over-year change in earnings per share. | +10.5% | -- | -- |
ROIC Return generated from invested capital. | 11.2% | -- | -- |
Gross Margin / Operating Margin Profitability before and after operating expenses. | 33.7% / 12.5% | -- / -- | -- |
| On growth, XOM posted revenue growth of +9.1% and TTM EPS growth of +10.5%. ABT, by comparison, posted revenue growth of -- and TTM EPS growth of --.On profitability, XOM recorded a gross margin of 33.7%, an operating margin of 12.5%, and ROIC of 11.2%. For ABT, the corresponding figures were --, --, and --.Overall, the indicators do not show a clear overall leader between the two companies. | |||
| XOM vs ABT Valuation & Balance Sheet | |||
Free Cash Flow Yield Free cash flow as a percentage of market capitalization. | -- | -- | -- |
Net Debt / EBITDA Net debt relative to EBITDA; a negative value indicates net cash. | -- | -- | -- |
Dividend Yield / Payout Ratio Dividend returns relative to share price and the share of earnings paid as dividends. | -- / 69.9% | -- / 79.0% | -- |
| The two stocks offer a similar free cash flow yield, indicating comparable valuations. The two companies have similar balance-sheet leverage, while the two stocks offer the same dividend yield. Overall, the two stocks differ mainly in valuation, financial strength and dividend income. | |||
| XOM vs ABT Returns & Risk | |||
Total Return (Dividend-Adjusted) Cumulative return over 1, 5 and 10 years, including dividends. | 1Y: +41.9%5Y: +182.2%10Y: +95.7% | 1Y: -22.7%5Y: -16.8%10Y: +148.2% | ABTWin |
30-Day Realized Volatility Annualized volatility based on the past 30 days of daily returns. | 24.5% | 19.7% | ABTWin |
Beta (5Y vs S&P 500) Sensitivity to market movements; above 1 indicates greater market volatility. | 0.39 | 0.50 | XOMWin |
| XOM has delivered stronger long-term returns, but the risk indicators show mixed results. | |||
XOM vs ABT Valuation & Dividend Metrics
Review XOM compared with ABT across valuation, cash flow and dividend metrics, including P/E, forward P/E, free cash flow yield and dividend yield. These figures are provided for reference only and do not represent a fair-value estimate, price target or investment recommendation.
| Metric | XOM | ABT | Comparison results |
|---|---|---|---|
Market Cap | $652.60B | $179.04B | XOMWin |
P/E (TTM) | -- | -- | -- |
P/S | -- | -- | -- |
EV/EBITDA | -- | -- | -- |
Dividend Yield | -- | -- | -- |
XOM vs ABT Profitability Over Time
Compare XOM and ABT across gross margin and operating margin trends over time to understand how each company's profitability has changed. Based on reported financial data only; not a forecast or investment advice.
| TTM | 3Y Avg | 5Y Avg | 10Y Avg | |
|---|---|---|---|---|
| XOM | 31.8% | 32.2% | 32.8% | 32.1% |
| ABT | 56.4% | 55.7% | 56.0% | 56.1% |
Technical & Fundamental Stock Analysis
RSI (14, daily)
XOM 52.38 • ABT 41.89
Measures short-term price momentum and helps identify possible overbought or oversold conditions.
50/200-DMA Position
XOM 50D Above / 200D Above • ABT 50D Below / 200D Below
Shows whether the stock is trading above or below its medium- and long-term trend lines.
R&D % of Revenue
XOM 0.0% • ABT --
Shows how much of revenue is invested in research and development.
Share Count Trend (3Y)
XOM Increased • ABT Stable
Shows whether the company's share count has increased or decreased over the past three years.
Company Profiles
ExxonMobil Holdings Corporation
Integrated Oil & Gas
ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil worldwide. In 2025, it produced 3.3 million barrels of liquids and 8.4 billion cubic feet of natural gas per day. At the end of 2025, reserves were 19.3 billion barrels of oil equivalent, 69% of which were liquids. The company is one of the world's largest refiners, with a total global refining capacity of 4.1 million barrels of oil per day, and is one of the world's largest manufacturers of commodity and specialty chemicals.
Abbott Laboratories
Health Care Equipment
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Trade XOM & ABT Stock Futures on MEXC
Trade USDT-margined Stock Futures referencing XOM and ABT on MEXC, with 24/7 access and leverage of up to 10x. These products are derivatives, do not represent ownership of the underlying shares and involve a significant risk of loss.
Everything You Need to Know About XOM vs ABT Stocks
What is MEXC Stock Compare?
MEXC Stock Compare is a side-by-side US stock comparison tool. It helps users compare two companies across stock price performance, market cap, valuation, growth, profitability, balance-sheet strength, dividends and risk. The results are provided for research purposes only and do not constitute investment advice.
Which metrics should I use to evaluate a company's growth?
Start with revenue growth to see how quickly the business is expanding, then review EPS growth to determine whether that growth is translating into higher earnings per share. Gross margin, operating margin and ROIC help assess the quality of that growth by showing profitability and capital efficiency. A company with fast revenue growth but declining margins may be expanding without improving its earnings quality.
How do XOM and ABT compare in growth and profitability?
In the latest reported period, XOM recorded revenue growth of +9.1% and TTM EPS growth of +10.5%, compared with -- and -- for ABT. The indicators do not show a clear overall leader between the two companies. This comparison is based on reported financial metrics and does not predict future performance.
What is the difference between P/E (TTM) and Forward P/E?
P/E (TTM) compares the current share price with actual earnings reported over the past 12 months. Forward P/E uses estimated earnings for the next 12 months, so it reflects market expectations but depends on forecasts that may change. Both ratios should be considered alongside growth, profitability and industry peers.
How do the risk profiles of XOM and ABT compare?
XOM has a 30-day realized volatility of 24.5% and a five-year Beta of 0.39, compared with 19.7% and 0.50 for ABT. The risk indicators show mixed results. These indicators describe historical price movements and market sensitivity, but they do not cover every source of investment risk.
What do dividend yield and payout ratio indicate?
Dividend yield shows the annual dividend relative to the current share price, while the payout ratio shows how much of a company's earnings is distributed as dividends. A higher yield may provide more income, but it can also rise because the share price has fallen. Dividend sustainability should therefore be considered together with earnings, cash flow and the payout ratio.
How should I compare a high-growth stock with a lower-valued stock?
A high-growth stock may trade at a higher valuation if investors expect its revenue and earnings to continue expanding. A lower-valued stock may offer a more conservative entry point, but the lower valuation could also reflect slower growth or higher business risk. Growth, valuation, profitability, cash flow and risk should therefore be considered together.
Which is the better stock, XOM or ABT?
There is no single answer for every investor. Growth-focused investors may place greater weight on revenue growth, EPS growth and ROIC, while income-focused investors may prioritize dividend yield and payout sustainability. Investors with lower risk tolerance may focus more on volatility, Beta and balance-sheet strength. MEXC Stock Compare presents the relevant metrics but does not provide a buy or sell recommendation.
Can I trade XOM and ABT as RealStocks on MEXC?
Eligible users can trade XOM and ABT as real US stocks through MEXC RealStocks if both stocks are currently supported. Users must first open and verify a RealStocks account with MEXC's partner licensed broker. RealStocks represents ownership of actual shares rather than tokenized stock exposure. Availability may vary by stock and region, so users should check the corresponding RealStocks trading page before placing an order.
Disclaimer
The stock prices, financial metrics, comparison results and related information displayed on this page are sourced from third-party providers and are provided for informational and educational purposes only. Data may be delayed, incomplete or inaccurate, and MEXC does not guarantee its accuracy, completeness or timeliness. The comparisons and automated summaries do not constitute financial, investment, legal or tax advice, nor a recommendation to buy, sell or hold any security or financial product. Past performance is not indicative of future results. Users should independently verify the information and assess their own objectives, financial circumstances and risk tolerance before making any decision. Where MEXC stock futures or other derivative products are referenced, such products do not represent ownership of the underlying shares and may involve leverage and a substantial risk of loss. Product availability is subject to applicable laws and regional restrictions.